Statements (53)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
mental disorder
mood disorder |
| gptkbp:canBeManagedBy |
gptkb:psychotherapy
gptkb:drug |
| gptkbp:class |
gptkb:DSM-5
gptkb:ICD-10 |
| gptkbp:complication |
suicide
substance abuse occupational impairment legal problems relationship difficulties |
| gptkbp:diagnosedBy |
gptkb:DSM-5_criteria
psychiatric evaluation |
| gptkbp:differentialDiagnosis |
gptkb:Bipolar_II_disorder
gptkb:major_depressive_disorder schizophrenia borderline personality disorder |
| gptkbp:firstDescribed |
gptkb:Emil_Kraepelin
|
| gptkbp:hasDepressiveEpisodeDuration |
at least 2 weeks
|
| gptkbp:hasManicEpisodeDuration |
at least 7 days
|
| gptkbp:hasNoCure |
true
|
| https://www.w3.org/2000/01/rdf-schema#label |
Bipolar I disorder
|
| gptkbp:ICD-10_code |
F31.1
|
| gptkbp:offersCourse |
episodic
chronic recurrent |
| gptkbp:onset |
late adolescence to early adulthood
|
| gptkbp:partOf |
bipolar spectrum
|
| gptkbp:prevalence |
~1% of population
|
| gptkbp:riskFactor |
substance abuse
genetic predisposition stressful life events family history of bipolar disorder |
| gptkbp:symptom |
psychosis
increased energy insomnia suicidal ideation irritability impulsivity decreased need for sleep grandiosity racing thoughts depressive episode manic episode |
| gptkbp:treatment |
gptkb:psychotherapy
gptkb:carbamazepine lithium antipsychotics electroconvulsive therapy mood stabilizers valproate |
| gptkbp:bfsParent |
gptkb:Bipolar_affective_disorder
|
| gptkbp:bfsLayer |
6
|